Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Surveying multiple sclerosis in the United Kingdom.

Literature DB >> 7823061

Surveying multiple sclerosis in the United Kingdom.

N Robertson, A Compston.

Abstract

Entities: Disease

Mesh：

Year: 1995 PMID： 7823061 PMCID： PMC1073260 DOI： 10.1136/jnnp.58.1.2

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

× No keyword cloud information.

34 in total

1. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority.

Authors: M H Roberts; J P Martin; D L McLellan; S A McIntosh-Michaelis; A J Spackman
Journal: J Neurol Neurosurg Psychiatry Date: 1991-01 Impact factor: 10.154

Review 2. Multiple sclerosis: changing times.

Authors: J F Kurtzke
Journal: Neuroepidemiology Date: 1991 Impact factor: 3.282

3. A prevalence survey of multiple sclerosis in Sussex.

Authors: M Rice-Oxley; E S Williams; J E Rees
Journal: J Neurol Neurosurg Psychiatry Date: 1995-01 Impact factor: 10.154

4. The distribution of multiple sclerosis in the United Kingdom.

Authors: R J Swingler; D Compston
Journal: J Neurol Neurosurg Psychiatry Date: 1986-10 Impact factor: 10.154

5. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern.

Authors: M Grønning; T Riise; G Kvåle; H Nyland; J P Larsen; J A Aarli
Journal: Neuroepidemiology Date: 1991 Impact factor: 3.282

6. An immunogenetic heterogeneity in multiple sclerosis.

Authors: J Hillert; M Grönning; H Nyland; H Link; O Olerup
Journal: J Neurol Neurosurg Psychiatry Date: 1992-10 Impact factor: 10.154

7. The epidemiology of multiple sclerosis: the Iceland model. Onset-adjusted prevalence rate and other methodological considerations.

Authors: C M Poser; J Benedikz; P L Hibberd
Journal: J Neurol Sci Date: 1992-09 Impact factor: 3.181

8. Prevalence of multiple sclerosis in five rural Suffolk practices.

Authors: M J Lockyer
Journal: BMJ Date: 1991-08-10

9. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.

Authors: G Sharpe; S E Price; A Last; R J Thompson
Journal: J Neurol Neurosurg Psychiatry Date: 1995-01 Impact factor: 10.154

Review 10. Epidemiologic evidence for multiple sclerosis as an infection.

Authors: J F Kurtzke
Journal: Clin Microbiol Rev Date: 1993-10 Impact factor: 26.132

13 in total

Review 1. Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors: Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal: Neurology Date: 2010-06-08 Impact factor: 9.910

2. Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.

Authors: N Robertson; J Deans; M Fraser; D A Compston
Journal: J Epidemiol Community Health Date: 1996-06 Impact factor: 3.710

3. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors: M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal: J Neurol Neurosurg Psychiatry Date: 2003-01 Impact factor: 10.154

Surveying multiple sclerosis in the United Kingdom.

1. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority.

Review 2. Multiple sclerosis: changing times.

3. A prevalence survey of multiple sclerosis in Sussex.

4. The distribution of multiple sclerosis in the United Kingdom.

5. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern.

6. An immunogenetic heterogeneity in multiple sclerosis.

7. The epidemiology of multiple sclerosis: the Iceland model. Onset-adjusted prevalence rate and other methodological considerations.

8. Prevalence of multiple sclerosis in five rural Suffolk practices.

9. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.

Review 10. Epidemiologic evidence for multiple sclerosis as an infection.

Review 1. Multiple sclerosis, vitamin D, and HLA-DRB1*15.

2. Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.

3. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Review 4. Genetic epidemiology of multiple sclerosis.

5. The prevalence of multiple sclerosis in the Leeds Health Authority.

6. Prevalence of multiple sclerosis in Rochdale.

7. The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.

8. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.

9. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.

10. Multiple sclerosis in the north Cambridgeshire districts of East Anglia.